LANGLEY DUBOSE: Open Payments
NPI 1699551390 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,847 in 195 payments from 19 companies in 2025. Trend: 2023 $49 · 2024 $3,626 · 2025 $3,847
Food & beverage: $3,739Education: $108
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $513 |
| Arcutis Biotherapeutics, Inc. | 9 | $436 |
| UCB, Inc. | 12 | $317 |
| Galderma Laboratories, L.P. | 24 | $298 |
| Amgen Inc. | 15 | $274 |
| Lilly USA, LLC | 10 | $236 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $197 |
| Janssen Biotech, Inc. | 15 | $194 |
| Regeneron Healthcare Solutions, Inc. | 7 | $178 |
| E.R. Squibb & Sons, L.L.C. | 12 | $162 |
Products named: Zoryve, DUPIXENT, Bimzelx, SKYRIZI, TREMFYA, OTEZLA, Sotyktu, RINVOQ.
Industry payments across SC — which companies pay providers there.
